Germline duplication of ATG2B and GSKIP predisposes to familial myeloid malignancies.
about
Recent advances in understanding myelofibrosis and essential thrombocythemiaRuxolitinib in the treatment of polycythemia vera: patient selection and special considerationsWhole-exome sequencing identifies novel candidate predisposition genes for familial polycythemia vera.The A-kinase Anchoring Protein GSKIP Regulates GSK3β Activity and Controls Palatal Shelf Fusion in Mice.Evaluation of Patients and Families With Concern for Predispositions to Hematologic Malignancies Within the Hereditary Hematologic Malignancy Clinic (HHMC).Genetic hierarchy and temporal variegation in the clonal history of acute myeloid leukaemia.Molecular determinants of pathogenesis and clinical phenotype in myeloproliferative neoplasms.Diagnosis, risk stratification, and response evaluation in classical myeloproliferative neoplasms.The future of clinical cancer genomics.Blast-phase myeloproliferative neoplasms: risk factors and treatment approaches.Myelodysplastic syndromes and acute leukemia with genetic predispositions: a new challenge for hematologists.Advances in understanding the pathogenesis of familial myeloproliferative neoplasms.Predispositions to Leukemia in Down Syndrome and Other Hereditary Disorders.The A-Kinase Anchoring Protein (AKAP) Glycogen Synthase Kinase 3β Interaction Protein (GSKIP) Regulates β-Catenin through Its Interactions with Both Protein Kinase A (PKA) and GSK3βATG2B and GSKIP: 2 new genes predisposing to myeloid malignancies.Childhood cancer predisposition syndromes-A concise review and recommendations by the Cancer Predisposition Working Group of the Society for Pediatric Oncology and Hematology.Germline transmission of LNKE208Q variant in a family with myeloproliferative neoplasms.How I diagnose and manage individuals at risk for inherited myeloid malignancies.
P2860
Q26748543-F54BF4A8-06DD-4CEF-BC0E-282410537323Q28078404-E64C081E-F243-474D-A612-E7AF01C072A0Q33582246-7EEDBBC3-EF9B-4051-99AF-C4AEB0B40DB7Q36442367-308060C2-897D-49A2-A27A-10D5FB33E181Q37047952-B5F924EC-205C-4F0A-B43C-E61375BF91D3Q37191875-98352F3A-0FE9-485C-8CF1-D5F944BAFCD3Q37555785-E7842072-C53E-43B7-A204-12A94B0D95F5Q37679175-577538F8-5D35-4031-B4CC-88520AE1883FQ38789283-F3F88D46-F1D1-4026-B42F-ADC1CE731875Q38844669-AC082FB5-4084-46F2-85DB-8B307D554773Q39000607-E7C1412E-5B29-4786-A097-540A596120E7Q39263948-F0BBE0E8-E08F-45D9-B4AB-DAF89391AB9AQ39350289-CC234E35-D72D-4A18-B119-4CA0AA7E5E06Q41049648-F343EBA2-5A75-4353-9141-3CC19969D863Q42729833-923174BD-055B-4403-86EB-43D770D2C778Q52793910-9BD3F949-5438-4C35-922F-70D6408296F7Q53779999-3A64AD8F-CC8E-4668-930B-8155398B365BQ55155177-48B987B8-21A8-413D-B2F1-FC0E900B0A8C
P2860
Germline duplication of ATG2B and GSKIP predisposes to familial myeloid malignancies.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Germline duplication of ATG2B and GSKIP predisposes to familial myeloid malignancies.
@en
Germline duplication of ATG2B and GSKIP predisposes to familial myeloid malignancies.
@nl
type
label
Germline duplication of ATG2B and GSKIP predisposes to familial myeloid malignancies.
@en
Germline duplication of ATG2B and GSKIP predisposes to familial myeloid malignancies.
@nl
prefLabel
Germline duplication of ATG2B and GSKIP predisposes to familial myeloid malignancies.
@en
Germline duplication of ATG2B and GSKIP predisposes to familial myeloid malignancies.
@nl
P2093
P2860
P50
P356
P1433
P1476
Germline duplication of ATG2B and GSKIP predisposes to familial myeloid malignancies.
@en
P2093
Albert Najman
Alberta Palazzo
Antonio Di Stefano
Boris Keren
Caroline Marty
Christine Bellanné-Chantelot
Christine Delaunay-Darivon
Cécile Saint-Martin
Emna Mahfoudhi
Florence Pasquier
P2860
P2888
P304
P356
10.1038/NG.3380
P407
P577
2015-08-17T00:00:00Z